Rochester Clinical Research is now enrolling adults who recently quit smoking for a study testing a once-weekly investigational medication that may help them stay smoke-free and avoid starting cigarettes again.
Rochester Clinical Research is now enrolling adults who recently quit smoking for a study testing a once-weekly investigational medication that may help them stay smoke-free and avoid starting cigarettes again.
Researchers are looking to learn if the investigational medicine may help reduce cravings, support staying smoke-free, and lower the chance of starting cigarettes again.
You may qualify if you:
Adults 18 to 80 years of age may qualify for a study evaluating an investigational treatment for irritable bowel syndrome […]
Are you 50 or older and in good general health? If you’ve had a pneumonia shot in the past (like Prevnar® or Pneumovax®), you […]
High blood pressure (hypertension) occurs when the force of blood against artery walls is consistently too high. Over time, this […]
Researchers are studying a new investigational medication, CRB-913, which works on pathways involved in appetite and metabolism. This study aims to […]
Influenza (flu) is a contagious respiratory illness that can lead to serious complications, especially in older adults and individuals with […]
We are currently enrolling a weight loss study evaluating the safety, tolerability and effectiveness of a GLP-1 and GIP medication. If […]